Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-02 Purchase | 2024-08-05 3:57 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 373,569 | $1.2655 | $472,757 | 14,250,000 (Indirect) | View |
| 2024-07-30 Purchase | 2024-07-31 4:10 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 273,730 | $1.3115 | $359,010 | 13,876,421 (Indirect) | View |
| 2024-07-18 Purchase | 2024-07-22 4:03 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 154,722 | $1.3043 | $201,808 | 13,602,691 (Indirect) | View |
| 2024-07-02 Purchase | 2024-07-05 2:46 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 352,397 | $1.1518 | $405,894 | 13,447,969 (Indirect) | View |
| 2024-06-27 Purchase | 2024-07-01 1:39 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 1,543,434 | $1.1287 | $1,742,075 | 13,095,572 (Indirect) | View |
| 2024-06-14 Purchase | 2024-06-18 4:04 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 545,000 | $1.1527 | $628,206 | 11,552,134 (Indirect) | View |
| 2024-06-11 Purchase | 2024-06-13 6:04 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 1,611,200 | $1.1059 | $1,781,897 | 11,007,134 (Indirect) | View |
| 2024-03-01 Purchase | 2024-03-05 4:58 pm | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 14,500 | $1.2383 | $17,955 | 28,863 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-01 Exercise | 2024-10-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,467 | $0 | 1,435,909 (Direct) | View |
| 2024-10-01 Tax Withholding | 2024-10-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,722 | $1.18 | 1,435,909 (Direct) | View |
| 2024-09-01 Exercise | 2024-09-04 7:52 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 1,000 | $0 | 24,697 (Direct) | View |
| 2024-09-01 Tax Withholding | 2024-09-04 7:52 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 286 | $1.18 | 24,697 (Direct) | View |
| 2024-09-01 Exercise | 2024-09-04 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,466 | $0 | 1,438,631 (Direct) | View |
| 2024-09-01 Tax Withholding | 2024-09-04 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,722 | $1.18 | 1,438,631 (Direct) | View |
| 2024-08-09 Exercise | 2024-08-13 4:15 pm | N/A 2024-08-12 | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 43,548 | $0 | 1,356,153 (Direct) | View |
| 2024-08-09 Exercise | 2024-08-13 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 43,548 | $0.72 | 1,356,153 (Direct) | View |
| 2024-08-01 Tax Withholding | 2024-08-05 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,722 | $1.32 | 1,397,805 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,467 | $0 | 1,397,805 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,467 | $0 | 1,400,527 (Direct) | View |
| 2024-07-01 Tax Withholding | 2024-07-03 4:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,722 | $1.15 | 1,400,527 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 4:15 pm | N/A 2034-06-05 | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 20,543 | $0 | 20,543 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 4:15 pm | N/A 2034-06-05 | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 20,543 | $0 | 20,543 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 4:15 pm | N/A 2034-06-05 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 20,543 | $0 | 20,543 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 4:15 pm | N/A 2034-06-05 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 20,543 | $0 | 20,543 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 4:15 pm | N/A 2034-06-05 | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 20,543 | $0 | 20,543 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 4:15 pm | N/A 2034-06-05 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 20,543 | $0 | 20,543 (Direct) | View |
| 2024-06-01 Tax Withholding | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,722 | $1.03 | 1,403,249 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,466 | $0 | 1,403,249 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 4,660 | $0 | 28,732 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 4,660 | $0 | 33,523 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 4,660 | $0 | 53,163 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 4,660 | $0 | 12,523 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 4,660 | $0 | 28,732 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 4,660 | $0 | 16,961 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 4,660 | $0 | 43,364 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 4,660 | $0 | 443,622 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,467 | $0 | 1,405,971 (Direct) | View |
| 2024-05-01 Tax Withholding | 2024-05-03 4:20 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 2,784 | $1.26 | 1,405,971 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 5:00 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 9,467 | $0 | 1,408,755 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-03 5:00 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO | 3,224 | $1.26 | 1,408,755 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal Interim President and CEO | 3,223 | $1.24 | 1,411,979 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal Interim President and CEO | 9,466 | $0 | 1,411,979 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 21,283 | $1.24 | 258,826 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 5:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 73,425 | $0 | 258,826 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:02 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 1,417 | $1.24 | 29,833 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 5:02 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 4,975 | $0 | 29,833 (Direct) | View |
Ownership | 2024-02-08 10:47 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 0 | $0 | 9,395,934 (Indirect) | View |
| 2024-02-01 Option Award | 2024-02-05 7:36 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Walker Neal Interim CEO | 639,000 | $0 | 639,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:31 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 413,000 | $0 | 570,334 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 7:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 2,583 | $1.2 | 570,334 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-05 7:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 7,500 | $0 | 570,334 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:29 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 413,000 | $0 | 492,017 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 7:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 6,421 | $1.2 | 492,017 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-05 7:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 18,750 | $0 | 492,017 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:27 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 413,000 | $0 | 413,000 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-01-03 4:47 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 2,536 | $1.05 | 42,925 (Direct) | View |
| 2024-01-01 Exercise | 2024-01-03 4:47 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 7,500 | $0 | 42,925 (Direct) | View |